# Miracle

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/miracle

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Website: www.innomiracle.com
- Latest round: Angel (Dec 29, 2023)
- Investors on record: 3

## About

Founded in 2021 and based in Suzhou, China, Miracle is a medical company that focuses on miRNA-based technology platforms in the diagnosis of multiple diseases. It established R&D centers and manufacturing plants in Suzhou, Shenzhen, and Los Angeles. Chang Su, the founder of the company, graduated from Nanjing University, and was an assistant professor at the University of North Texas. In December 2023, Miracle closed an undisclosed amount of angel funding.

Miracle's business is research and development of microRNA detection methods and related products. It has a miRNA-based technology platform for the diagnosis of diseases. Products include serum and plasma miRNA extraction kits, miRNA RT reverse transcription reagents, and miRNA qPCR reagents. Its products can be used for the diagnosis of Alzheimer's disease and cancer screening.

The company will use the funding to advance the clinical registration of two product pipelines.

## Funding rounds

- Angel, Dec 29, 2023 — Star Capital, Langrun Lifang, Yinsong Technology

## Investors

- Star Capital — Angel
- Langrun Lifang — Angel
- Yinsong Technology — Angel